Liraglutide injection into the VMH of mice induced weight loss and increased thermogenetic activity, as evidenced by elevated uncoupling protein 1 expression in both BAT and white adipose tissue, with adenosine monophosphate-activated protein kinase (AMPK) signaling in the VMH required as a mediator [71]
The vagus nerve can also inhibit the release of pro-inflammatory cytokines in such a way that mediates selective cholinergic activation in the inflammatory response, thereby improving inflammation and obesity (97, 98, 105)
Multiple users reported mild side effects including stomach discomfort and bloating, with zero weight loss to show for it
The most frequently reported side effects include: Nausea (affecting approximately 1040% of patients, depending on the specific medication) Vomiting Diarrhoea Constipation Abdominal discomfort or bloating Reduced appetite These effects typically occur because GLP-1 medications slow gastric emptying and affect gut motility
The platform runs intake and logistics
Adeva-Andany MM, Calvo-Castro I, Fernndez-Fernndez C, Donapetry-Garca C, Pedre-Pieiro AM